Literature DB >> 1282714

Review of current and future approaches to the management of benign prostatic hyperplasia.

J C Gingell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282714      PMCID: PMC2399459          DOI: 10.1136/pgmj.68.803.702

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  31 in total

1.  The intraprostatic spiral. New treatment for urinary retention.

Authors:  K K Nielsen; P Klarskov; J Nordling; J T Andersen; H H Holm
Journal:  Br J Urol       Date:  1990-05

2.  European experience with the urethral Wallstent for urethral strictures.

Authors:  M H Ashken; C Coulange; E J Milroy; J P Sarramon
Journal:  Eur Urol       Date:  1991       Impact factor: 20.096

3.  Use of the Wallstent endourethral prosthesis in the treatment of recurrent urethral strictures.

Authors:  J P Sarramon; F Joffre; P Rischmann; H Rousseau; A ElDin
Journal:  Eur Urol       Date:  1990       Impact factor: 20.096

4.  Local hyperthermia of the prostate gland for the treatment of benign prostatic hypertrophy and urinary retention. A preliminary report.

Authors:  A Lindner; J Golomb; Y Siegel; A Lev
Journal:  Br J Urol       Date:  1987-12

5.  Indoramin--an effective new drug in the management of bladder outflow obstruction.

Authors:  J W Iacovou; M Dunn
Journal:  Br J Urol       Date:  1987-12

6.  Treatment of benign prostatic hyperplasia by androgen deprivation: effects on prostate size and urodynamic parameters.

Authors:  R J Bosch; D J Griffiths; J H Blom; F H Schroeder
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

7.  A critical evaluation of the results of transurethral resection of the prostate.

Authors:  C P Chilton; R J Morgan; H R England; A M Paris; J P Blandy
Journal:  Br J Urol       Date:  1978-12

8.  The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report.

Authors:  J McLoughlin; R Jager; P D Abel; A el Din; A Adam; G Williams
Journal:  Br J Urol       Date:  1990-07

9.  Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.

Authors:  P C Walsh; G M Hutchins; L L Ewing
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  Benign prostatic hypertrophy: retrograde transurethral dilation of the prostatic urethra in humans. Work in progress.

Authors:  F Castaneda; P Reddy; N Wasserman; J Hulbert; G Lund; J G Letourneau; D W Hunter; W R Castaneda-Zuniga; K Amplatz
Journal:  Radiology       Date:  1987-06       Impact factor: 11.105

View more
  1 in total

Review 1.  Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia.

Authors:  D H Peters; E M Sorkin
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.